life

Cell Proliferation Kit Outperforms the Competition in the Range of Cells Typically Counted

Quantitating cell number is more accurate using the Quantos cellproliferation assay kit Genetic Applications LLC cell proliferation assay kitprovides a simple, reproducible method to assess the number of cells present invarious tissue culture dish formats. In this st...

Cell Proliferation Assays

The cell proliferation assay is an important tool in the assessment of the immune system function and in the search for new drugs. Productivity with this technique has been limited by the lack of automated, high throughput sample processing and counting equipment. The MicroMate harvester and the TopCount Microplate Scintillation Counter help r...

British, Wisconsin firms explore life-science opportunities together

"We're looking for companies with complimentary products or complimentary technologies," said Frank Phillips, vice consul for the <a href="http://www.brit...

Quantitative Measurement of Cell Proliferation Using the BrdU ELISA: A Comparison Between Colorimetric and Chemiluminescent Detection

Quantitative determination of DNA synthesis in cellcultures is now a routine procedure in many laboratories.Protocols are available for various applications,especially in cell culture systems. The effects of growthfactors, inhibition of cell division by exogenous factor...

Cell Proliferation and Viability Measurement

The quantification of cellular growth, including proliferationand viability, has become an essential tool in anylaboratory working on cell-based studies. Such techniquesenable not only the optimization of cell cultureconditions, but also the determination of growth factorand...

measuring cell proliferation with SpectraMax M5, M2 and Gemini microplate readers using the CyQUANT Cell Proliferation Assay

Cathy Olsen, Ph.D., Molecular Devices Corporation, 1311 Orleans Dr., Sunnyvale, CA 94089....

Cell Proliferation Assay Using the Benchmark Plus Microplate Spectrophotometer

William C Heiser, PhD and Ma Theresa Redila-Flores, Bio-Rad Laboratories, Inc . , Hercules, CA 94547 USA An accurate and rapid assessment of viable cell number and proliferation is often required for in vitro and in vivo experiments. These assessments are necessary and useful for analysi...

Identification of cells in S phase using the Cell Proliferation Fluorescence Kit and IN Cell Analyzer 1000

The cell cycle is of key importance to many areas of drug discovery. On the one hand this fundamental process provides the opportunity to discover new therapeutic targets for anti-cancer agents, and on the other hand drugs and targets in other therapeutic areas must be tested for undesirable effects on the cell cycle. <P >The Cell Proliferation Fluorescence Kit is...

Exploiting the Life Science Data Explosion to Speed New Drug Discovery

This paper discusses key problems and opportunities created by the explosion in both the degree (volume) and complexity of life science data available today, and presents a strategic and technological approach to data integration that enables r...

Phosphorescence lifetime measured using the SPEX phosphorimeter

A phosphorimeter integral to the SPEX system can uncover important information on various systems of chemical and biochemical interest, by revealing data normally masked by intense but rapid fluorescence. <P>This Application Not...

Automation of the Eppendorf Perfectprep BAC 96 DNA Kit on the Caliper Life Sciences Sciclone ALH 3000

Applied Science and Technology Department, Caliper Life Sciences Inc., Hopkinton, MA 01748 Brinkmann An Eppendorf Company, Westbury, NY Eppendorf 5 Prime, Inc. Boul...

World Class Life Science and Pharmaceutical Companies Leverage DoveBid s Global Reach for Asset Management and Disposition

), the global leader in capital asset auction and valuation services, announced today it will be conducting its 50th global Life Sciences / BioPharma Exchange auction online, on August 15, 2006. The event...

Midwest life science stocks kept sizzling in Q2

going from a one percent decline to a very robust eight percent growth for the first half. Not far behind was the <a href="http://www.nasdaq...

Midwest life science stocks sizzle in a tepid first quarter

The major life scie...

A Midwest life-science odyssey comes full circle

D...

A Midwest small-cap, life-science surprise package

B...

Madison life-science firms agree to co-develop kidney product

, have entered into a license and supply agreement to commercialize products to treat...

2006: A mixed blessing for Midwest life science companies

Th...

Financing life science: The ongoing saga

Let's start with the Initial Public Offering (IPO) market, which is how many investors used to make money (those that had inve...

Father of life patents downplays historic role

Chakrabarty, the first person to successfully patent life forms, visited Wisconsin this we...

Does Milwaukee need a life-science spark?

Mascari, director of development for , sa...

The top 10 misconceptions of life-science patents

The following is a list of some of the most common and most important misconceptions, surrounded by reality. Like most legal analysis, there are exceptions to any rule or guideline. I'm ho...

QBI Life Sciences snags $130,000 NIH grant

to create absorption profiles for early drug-stage candi...

Wisconsin investors the lifeblood of New Jersey biotech

This round of financing, coordinated through ., a Milwaukee investment banking firm, w...

Work-life imbalance - A global problem getting worse

This quote by a Dutch man is taken from a paper by Rhonda Rappaport, Suzan Lewi...

U.S. VC funding flat in 2005 while life science funding grows

Last week, we focused on...

The Israeli life science juggernaut

I was particularly interested in experiencing firsthand the Israeli Life Science juggernaut...

VC funding increased in third quarter with shining life sciences

By the way, Chicagoans will get not one but two chances to see and hear U.S. biotech guru Steve Burrill this coming week. He will be featured at the NanoCommerce event at McCormick Place in Chicago on Tuesday morning and he will co-produce this years iBIOMarketplace event at Navy Pier on...

RFID can be a matter of life and death in the medical world

"Everybody wants to focus on the supply chain now, and there are tremendous applications in health care a lot of ap...

The challenge of financing today's Midwest life science companies

There are now 48 Midwest VC groups in 16 states with combined capital of $2 billion under management that are affiliated with the ever...

Midwest large cap life science group strengthening in the third quarter

...

Midwest large cap life sciences mostly outperform market

Dow Jones down 3 percent Nasdaq National Market down 8 percent Nasdaq Biotech down 16% percent Amex Biotech do...

Western way of life is under attack from jihad sub-culture

Shortly after seven explosions ripped through four targets in central London, bond trader Matthew rode a borrowed bicycle from the citys Financial District to South Kensington to make certain his...

The future of work II: standard of working up, quality of work life down

Humans love to keep score. Nowadays there seems to be a scorecard or measurement index for just about everything from the cost of living to the cost of dying and everything in between. The problem with many of these measures is that they take a pure economic view of whatever is being measured. But conclusions about the economy or business can often be misleading whe...

Living the sweet life... in IT?

I took advantage of a recent stretch of unseasonably warm weather to relocate to my summer office (read screened-in porch). In between the e-mails and proposals, a conference call and some project planning, I couldn't help but notice the yellow finches zipping in and out from the feeder and one particularly spoiled cat stretched out in the sun to the fullest extent...

Midwest large-cap life-science sector is solid in first quarter

This week, we will take a look at the larger cap life science companies. Note that these results dont include further bad news for the pharmaceutical sector. You may have noticed headlines at the end of last week when P...

Life-science sector grabbed VC investment in 2004

Also, what does it me...

Life-science research plan is about more than stem cells

As more states line up to promote human embryonic stem-cell research, policymakers and investors will ask, Will it pay off for all? The most likely answer is no. But among those states poised to compete with Californias $3 billion initiative, Wisconsin may be the best positioned for success. Thats because the $750 million proposal advanced by Gov. Jim Doyle is not aimed at advancing stem...

Midwest angel investment in life sciences on the rise

There is good reason for this as most of the Midwests biotech companies are early stage in comparison to their ea...

The greatest life-science developments of 2004

1. Mercks taking Vioxx off the market due to potent cardiovascular side effects and the resultant scrutiny on the...